PRTN3 and androgen insensitivity syndrome: To figure out the independent effect of the NE and PR3 on the outcomes and evaluate the predictive power of plasma NE and PR3 for the unfavorable outcome, we adjust the potential confounders, which also needs to be further confirmed by external validation in multi-cohorts of AIS patients.